Riken launches iPS cell therapy pilot study
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Riken has launched a pilot study to assess the safety and feasibility of the transplantation of autologous in...Read more
BioAsia 2014: Innovation, collaboration identified as success keys
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2014
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...Read more
Japan to gather nanotechnology experts in 2014
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Japan is all set to host the 13th International Nanotechnology Exhibition and Conference, for three days from...Read more
Daiichi's thrombosis drug meets primary endpoint
Japan | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2013
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...Read more
Japan approves Crimzia for arthritis patients
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2012
Singapore: UCB Japan received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cim...Read more
URMC launches new heart device trial in Asia
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...Read more
Honeycomb lung treatment Pirespa in South Korea
Japan | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Bangalore: Seoul-based Ildong has received a marketing and manufacturing approval for idiopathic pulmonary fibrosis (IPF...Read more
Iran, Japan to collaborate on health projects
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2015
Singapore: Iranian health Minister, Dr Hassan Hashemi has signed an MoU with Japan's Minister for Health Labor and Welfa...Read more
Prima BioMed's immunotherapeutic drug secures Japanese patent
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...Read more
MSD Japan head: Regulatory bodies are purposely delaying approvals
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
The entire world is worried about drying up of research pipelines and continued decline in research productivity. This m...Read more
PPD forms joint venture in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2014
Singapore: Pharmaceutical Product Development (PPD) and Shin Nippon Biomedical Laboratories have formed a joint venture ...Read more
MD Anderson, Astellas collaborate to develop new drug for Acute Myeloid Leukemia
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2015
Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...Read more
Elsevier collaborates with Kanazawa Univ, Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Elsevier, a world-leading provider of scientific, technical and medical information products and services, h...Read more
Fujifilm to acquire US-based vaccine maker
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2014
Singapore: Japan's Fujifilm has inked a deal to acquire US-based Kalon Bio therapeutics, which has expertise in manufact...Read more
Daiichi Sankyo launches Methylene Blue Injection in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Mar, 2015
Japanese pharma major Daiichi Sankyo Company Limited has launched Methylene Blue Injection 50mg for the treatment of met...Read more
HUYA Bioscience completes cancer drug's first cohort study in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Mar, 2015
HUYA Bioscience International (HUYA) has completed the first cohort in a Phase 1 clinical trial in Japan of its cancer d...Read more
Amgen seeks approval for anti-cholesterol drug in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Mar, 2015
US-based Amgen has announced that an application seeking marketing approval of Repatha (evolocumab) for the treatment of...Read more
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2013
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...Read more